Abstract |
HIV-1 entry into CD4(+) T cells requires binding of the virus to CD4 followed by engagement of either the C-C chemokine receptor 5 (CCR5) or C-X-C chemokine receptor 4 (CXCR4) coreceptor. Pharmacologic blockade or genetic inactivation of either coreceptor protects cells from infection by viruses that exclusively use the targeted coreceptor. We have used zinc-finger nucleases to drive the simultaneous genetic modification of both ccr5 and cxcr4 in primary human CD4(+) T cells. These gene-modified cells proliferated normally and were resistant to both CCR5- and CXCR4-using HIV-1 in vitro. When introduced into a humanized mouse model of HIV-1 infection, these coreceptor negative cells engraft and traffic normally, and are protected from infection with CCR5- and CXCR4-using HIV-1 strains. These data suggest that simultaneous disruption of the HIV coreceptors may provide a useful approach for the long-term, drug-free treatment of established HIV-1 infections.
|
Authors | Chuka A Didigu, Craig B Wilen, Jianbin Wang, Jennifer Duong, Anthony J Secreto, Gwenn A Danet-Desnoyers, James L Riley, Phillip D Gregory, Carl H June, Michael C Holmes, Robert W Doms |
Journal | Blood
(Blood)
Vol. 123
Issue 1
Pg. 61-9
(Jan 02 2014)
ISSN: 1528-0020 [Electronic] United States |
PMID | 24162716
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- CCR5 protein, human
- CXCR4 protein, human
- Receptors, CCR5
- Receptors, CXCR4
- Receptors, Chemokine
- Endodeoxyribonucleases
|
Topics |
- Animals
- CD4-Positive T-Lymphocytes
(cytology, virology)
- Cell Proliferation
- Endodeoxyribonucleases
(metabolism)
- Female
- HEK293 Cells
- HIV Infections
(immunology, prevention & control, therapy)
- HIV-1
- Humans
- Male
- Mice
- Receptors, CCR5
(genetics)
- Receptors, CXCR4
(genetics)
- Receptors, Chemokine
(metabolism)
- Zinc Fingers
|